Company Filing History:
2 out of 1,187 
2 out of 2,077 
1 out of 832,812 Years Active: 2002-2009
Title: **Cecile-Marie D D Denis: Innovations in Cell Cycle Checkpoint Genes**
Introduction
Cecile-Marie D D Denis, an accomplished inventor based in Beerse, Belgium, holds a notable portfolio of three patents. His inventive work primarily revolves around advancements in mammalian cell cycle checkpoint genes and DNA repair mechanisms that have significant implications in biotechnology and medicine.
Latest Patents
Denis's latest patents include groundbreaking inventions related to Human and Murine Mus81 proteins. The first patent encompasses novel mammalian cell cycle checkpoint genes or DNA repair genes, presenting cDNA or genomic DNA, as well as isolated nucleic acids corresponding to these proteins. It further discusses expression vectors that incorporate such nucleic acids, along with transformed host cells, and methods to treat a cell utilizing these biological components. Another significant patent focuses on genes and proteins encoded by these mammalian checkpoint genes, detailing pharmaceutical compositions and methodologies for treating cells, which hold promise for therapeutic applications.
Career Highlights
Throughout his career, Denis has contributed significantly to the field of biotechnology, collaborating with esteemed institutions like The Scripps Research Institute and Janssen Pharmaceutica NV. His roles in these organizations have allowed him to push the boundaries of scientific research and innovation, particularly in molecular biology and genetics.
Collaborations
Denis has worked alongside notable colleagues, including Paul R. Russell and Jorge Eduardo Vialard. These collaborations have fostered a creative environment leading to advancements in their respective fields and have played a critical role in the success of Denis's inventions.
Conclusion
Cecile-Marie D D Denis's work in developing innovative solutions for cell cycle checkpoint genes and DNA repair mechanisms places him at the forefront of scientific innovation. His patents not only contribute to the advancement of medical technologies but also signify his dedication to improving therapeutic outcomes through research and collaboration.